/**/ RNS Number : 5128M IQ-AI Limited 22 September 2021 22 September 2021 IQ-AI Limited (“IQ-AI” or the “Company”) IQ-AI LIMITED AWARDED EU PATENT FOR DUAL-ECHO MR PERFUSION PROCESSSING Milwaukee – 22 September 2021: IQ-AI Limited (LSE: IQAI) (OTCQB: IQAIF), a developer and manufacturer of medical image processing platforms that have led to effective
/**/ RNS Number : 0638M IQ-AI Limited 17 September 2021 17 September 2021 IQ-AI Limited (“IQ-AI” or the “Company”) IB Software Chosen for Quantitative Accuracy and Automation IQ-AI Limited (LSE: IQAI) (OTCQB: IQAIF) today announced the sale of multiple licenses of Imaging Biometrics (IB) software for the automated generation of quantitative perfusion maps. The
IQ-AI’s Imaging Biometrics’ IB Neuro brain tumor software named part of standard imaging protocol IQ-AI Limited (LON:IQAI) — The investment firm explains how IB’s brain tumour imaging software benefits patients and their treatment teams, and why IB Neuro was solely included as the image post-processing component of the new standardised imaging protocol for brain tumours.
